63
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Design, Synthesis, Biological Evaluation and In-silico Docking Studies of Some Novel Imidazolone Derivatives As Potent Antimicrobial Containing Fluorine Agents

ORCID Icon, , , , &
Pages 469-496 | Received 24 Feb 2021, Accepted 10 Jun 2021, Published online: 13 Jul 2021
 

Abstract

Imidazolones are potent for their intense antimicrobial and mitigating exercises wherein, an assortment of imidazolone analogs 4-aryl-1-(4-chloro-3-fluorophenyl)-2-phenyl-1H-imidazol-5(4H)-ones (2a-o) and 4-aryl-2-phenyl-1-(4-(trifluoromethyl) phenyl)-1H-imidazol-5(4H)-ones (3a-o) were studied amalgamating them by using oxazolones and various aryl amines. Newly synthesized compounds were screened for in vitro activity towards bacterial as well as fungal pathogenic microscopic organisms. Among the synthesized imidazolone derivatives, compound 2f, 2g, 2i, 3b, 3h, and 3k showed moderate antibacterial action while 2d, 2j, 2m, 2n, 3e, 3g, and 3f furnished earmarked antifungal action. In-silico docking of all structures was performed for fungal and bacterial targets. Out of all novel imidazolones, the compounds 2e, 2o and 3o exhibited superior affinity against fungal target 14α-demethylase when compared with other compounds.

GRAPHICAL ABSTRACT

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.